| Philip A Rettenmaier, DO | |
|
700 Broadway, 2nd Floor, Fort Wayne, IN 46802-1402 | |
| (260) 424-9000 | |
| (260) 425-3029 |
| Full Name | Philip A Rettenmaier |
|---|---|
| Gender | Male |
| Speciality | Undersea And Hyperbaric Medicine |
| Experience | 43 Years |
| Location | 700 Broadway, Fort Wayne, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871593418 | NPI | - | NPPES |
| 200073610 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0011X | Preventive Medicine - Undersea And Hyperbaric Medicine | 02001284A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lutheran Hospital Of Indiana | Fort wayne, IN | Hospital |
| Bluffton Regional Medical Center | Bluffton, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lutheran Medical Group Llc | 4981751617 | 261 |
News Archive
Today, Citizens for Pennsylvania's Future (PennFuture), joined by leaders from the Group Against Smog and Pollution (GASP) and Clean Water Action, along with Dr. Evelyn O. Talbott of the University of Pittsburgh Graduate School of Public Health Department of Epidemiology and Allegheny County Council President Richard Fitzgerald, announced a major new campaign to reduce the fine soot pollution responsible for Pittsburgh's number one ranking for dirtiest air for two years running.
The next advance in treating major depression may relate to a group of brain chemicals that are involved in virtually all our brain activity, according to a study published today in Biological Psychiatry.
Life-extending drugs debut frequently, and they usually seem exorbitantly expensive when weighed against their promise of adding a few weeks or months of life to someone with a terminal illness. In these prostate-cancer cases, one new drug costs $5,000 a month, another $8,000 every three weeks and a third $93,000 for a full course of treatment.
Neurotez, Inc. today announced the grant of U.S. Patent number 8,227,408 by the United States Patent and Trademark Office covering the company's lead product candidate, Leptin. The patent protects use of the hormone Leptin for treating a progressive cognitive disease, disorder or condition, such as Alzheimer's disease (AD), resulting from accumulation of an amyloid peptide or for improving resilience of cognitive function by modulating the accumulation of the amyloid peptide in brain.
Asymptomatic patients who undergo treadmill exercise echocardiography (ExE) after coronary revascularization may be identified as being at high risk but those patients do not appear to have more favorable outcomes with repeated revascularization, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication. The article is part of the journal's Less is More series.
› Verified 4 days ago
| Entity Name | Associated Surgeons And Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083868269 PECOS PAC ID: 2668539818 Enrollment ID: O20090316000381 |
News Archive
Today, Citizens for Pennsylvania's Future (PennFuture), joined by leaders from the Group Against Smog and Pollution (GASP) and Clean Water Action, along with Dr. Evelyn O. Talbott of the University of Pittsburgh Graduate School of Public Health Department of Epidemiology and Allegheny County Council President Richard Fitzgerald, announced a major new campaign to reduce the fine soot pollution responsible for Pittsburgh's number one ranking for dirtiest air for two years running.
The next advance in treating major depression may relate to a group of brain chemicals that are involved in virtually all our brain activity, according to a study published today in Biological Psychiatry.
Life-extending drugs debut frequently, and they usually seem exorbitantly expensive when weighed against their promise of adding a few weeks or months of life to someone with a terminal illness. In these prostate-cancer cases, one new drug costs $5,000 a month, another $8,000 every three weeks and a third $93,000 for a full course of treatment.
Neurotez, Inc. today announced the grant of U.S. Patent number 8,227,408 by the United States Patent and Trademark Office covering the company's lead product candidate, Leptin. The patent protects use of the hormone Leptin for treating a progressive cognitive disease, disorder or condition, such as Alzheimer's disease (AD), resulting from accumulation of an amyloid peptide or for improving resilience of cognitive function by modulating the accumulation of the amyloid peptide in brain.
Asymptomatic patients who undergo treadmill exercise echocardiography (ExE) after coronary revascularization may be identified as being at high risk but those patients do not appear to have more favorable outcomes with repeated revascularization, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication. The article is part of the journal's Less is More series.
› Verified 4 days ago
| Entity Name | Lutheran Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164662805 PECOS PAC ID: 4981751617 Enrollment ID: O20090414000705 |
News Archive
Today, Citizens for Pennsylvania's Future (PennFuture), joined by leaders from the Group Against Smog and Pollution (GASP) and Clean Water Action, along with Dr. Evelyn O. Talbott of the University of Pittsburgh Graduate School of Public Health Department of Epidemiology and Allegheny County Council President Richard Fitzgerald, announced a major new campaign to reduce the fine soot pollution responsible for Pittsburgh's number one ranking for dirtiest air for two years running.
The next advance in treating major depression may relate to a group of brain chemicals that are involved in virtually all our brain activity, according to a study published today in Biological Psychiatry.
Life-extending drugs debut frequently, and they usually seem exorbitantly expensive when weighed against their promise of adding a few weeks or months of life to someone with a terminal illness. In these prostate-cancer cases, one new drug costs $5,000 a month, another $8,000 every three weeks and a third $93,000 for a full course of treatment.
Neurotez, Inc. today announced the grant of U.S. Patent number 8,227,408 by the United States Patent and Trademark Office covering the company's lead product candidate, Leptin. The patent protects use of the hormone Leptin for treating a progressive cognitive disease, disorder or condition, such as Alzheimer's disease (AD), resulting from accumulation of an amyloid peptide or for improving resilience of cognitive function by modulating the accumulation of the amyloid peptide in brain.
Asymptomatic patients who undergo treadmill exercise echocardiography (ExE) after coronary revascularization may be identified as being at high risk but those patients do not appear to have more favorable outcomes with repeated revascularization, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication. The article is part of the journal's Less is More series.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Philip A Rettenmaier, DO 2518 E Dupont Rd, Fort Wayne, IN 46825-1675 Ph: (260) 432-4400 | Philip A Rettenmaier, DO 700 Broadway, 2nd Floor, Fort Wayne, IN 46802-1402 Ph: (260) 424-9000 |
News Archive
Today, Citizens for Pennsylvania's Future (PennFuture), joined by leaders from the Group Against Smog and Pollution (GASP) and Clean Water Action, along with Dr. Evelyn O. Talbott of the University of Pittsburgh Graduate School of Public Health Department of Epidemiology and Allegheny County Council President Richard Fitzgerald, announced a major new campaign to reduce the fine soot pollution responsible for Pittsburgh's number one ranking for dirtiest air for two years running.
The next advance in treating major depression may relate to a group of brain chemicals that are involved in virtually all our brain activity, according to a study published today in Biological Psychiatry.
Life-extending drugs debut frequently, and they usually seem exorbitantly expensive when weighed against their promise of adding a few weeks or months of life to someone with a terminal illness. In these prostate-cancer cases, one new drug costs $5,000 a month, another $8,000 every three weeks and a third $93,000 for a full course of treatment.
Neurotez, Inc. today announced the grant of U.S. Patent number 8,227,408 by the United States Patent and Trademark Office covering the company's lead product candidate, Leptin. The patent protects use of the hormone Leptin for treating a progressive cognitive disease, disorder or condition, such as Alzheimer's disease (AD), resulting from accumulation of an amyloid peptide or for improving resilience of cognitive function by modulating the accumulation of the amyloid peptide in brain.
Asymptomatic patients who undergo treadmill exercise echocardiography (ExE) after coronary revascularization may be identified as being at high risk but those patients do not appear to have more favorable outcomes with repeated revascularization, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication. The article is part of the journal's Less is More series.
› Verified 4 days ago
Dr. Daniel J Simmonds, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 302 E Jefferson Blvd, Fort Wayne, IN 46802 Phone: 260-426-2644 Fax: 260-426-1914 | |
Dr. Vincent Paul Moore, MD, MPH Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 7221 Engle Rd Ste 220, Fort Wayne, IN 46804 Phone: 260-469-8223 Fax: 260-469-8201 | |
Thomas Savoie, D.O. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 621 Fox Hound Way Apt 1b, Fort Wayne, IN 46804 Phone: 219-436-3603 | |
Cynthia L Wellman, M.D. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 2200 Randallia Dr, Fort Wayne, IN 46805 Phone: 260-373-6070 Fax: 260-373-6704 | |
Michael Knipp, M.D., M.S. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 3103 E State Blvd, Fort Wayne, IN 46805 Phone: 260-373-9300 | |
Tungyun David Wu, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 3978 New Vision Dr, Fort Wayne, IN 46845 Phone: 260-672-4680 Fax: 260-458-5836 | |
Dr. Gregory Paul Kniss, D.O. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 9318 Airport Dr, Fort Wayne, IN 46809 Phone: 260-373-9330 Fax: 260-373-9340 |